Overview

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

Status:
COMPLETED
Trial end date:
2025-02-24
Target enrollment:
Participant gender:
Summary
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
Phase:
PHASE4
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
perfluorohexyl-octan